ZYTIGA (abiraterone) was approved in EU for treatment of prostate cancer before chemotherapy abiraterone inhibit ulcers the enzyme cytochrome P-450c17, a key enzyme in the synthesis of testosterone. Is used in combination with prednisone or prednisolone once daily, orally Previously ZYTIGA plus prednisone was approved exclusively during or after chemotherapy with docetaxel. Following ulcers the enlargement of prostate cancer can be treated approval ill men at an earlier stage of disease with ZYTIGA .
2013 (17) December ulcers (1) January (1) January (1) January (2) June (2) January (1) April (4) March (2) February (1) January (2) study prostate cancer treatment methods ZYTIGA (abiraterone) approved prior chemotherapy ... 2012 (1) December (1)
No comments:
Post a Comment